[Form 4] Nature's Sunshine Products Inc. Insider Trading Activity

Rhea-AI Filing Summary

Bryant J. Yates, EVP & President, Europe of Nature's Sunshine Products, reported two open-market sales of Common Shares in late August 2025, selling 5,000 shares on 08/26/2025 at $16.77 and 4,672 shares on 08/29/2025 at $16.71. After these transactions his beneficial ownership decreased from 102,170 shares to 97,498 shares. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Positive

• Timely disclosure of insider sales via a Form 4 filed and signed by attorney-in-fact
• Clear transaction details including dates, share amounts, and prices for both sales

Negative

• Insider selling of 9,672 shares reduced beneficial ownership from 102,170 to 97,498 shares
• No explanation provided in the filing for the reason or intended use of proceeds from the sales

Insights

Corporate Governance Expert

TL;DR: Insider sold a small portion of holdings via open-market transactions; filing shows timely disclosure.

The reporting person executed two market sales totaling 9,672 common shares across two dates at prices of $16.77 and $16.71, reducing beneficial ownership to 97,498 shares. The sales were reported on a single Form 4 filed by one reporting person and signed by counsel. This is a routine Section 16 disclosure consistent with required insider reporting and provides transparency into insider liquidity.

Securities Analyst

TL;DR: Transactions are straightforward insider dispositions with limited immediate implications for company fundamentals.

The reported disposals were open-market sales (transaction code S) with no derivatives involved. The absolute size—9,672 shares—represents a modest decrease relative to prior holdings and carries no additional detail such as plan-based transfers or exemptions. The filing contains only the transactions reported and does not disclose motive or use of proceeds.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yates Bryant J

(Last) (First) (Middle)

2901 WEST BLUEGRASS BLVD.

STE 100

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATURES SUNSHINE PRODUCTS INC [ NATR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President, Europe

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/26/2025		S		5,000	D	$16.77	102,170	D
Common Shares	08/29/2025		S		4,672	D	$16.71	97,498	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Nathan G. Brower as attorney-in-fact for Bryant J. Yates	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Bryant J. Yates report for NATR?

He reported two open-market sales: 5,000 shares on 08/26/2025 at $16.77 and 4,672 shares on 08/29/2025 at $16.71.

How many NATR shares does Bryant J. Yates beneficially own after these Form 4 filings?

97,498 shares were reported as beneficially owned following the transactions.

Were the reported transactions purchases, sales, or option exercises?

Both were sales (transaction code S) of common shares in the open market.

Was the Form 4 filed jointly or by one reporting person for NATR?

The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/04/2025.

Does the Form 4 explain why the insider sold the NATR shares?

No explanation or stated purpose for the sales is included in the filing.